| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10966990 | INFORLIFE | Midazolam in flexible bags |
Jun, 2038
(14 years from now) | |
Midazolam In 0.9% Sodium Chloride is owned by Inforlife.
Midazolam In 0.9% Sodium Chloride contains Midazolam.
Midazolam In 0.9% Sodium Chloride has a total of 1 drug patent out of which 0 drug patents have expired.
Midazolam In 0.9% Sodium Chloride was authorised for market use on 22 March, 2021.
Midazolam In 0.9% Sodium Chloride is available in solution;intravenous dosage forms.
The generics of Midazolam In 0.9% Sodium Chloride are possible to be released after 20 June, 2038.
Drugs and Companies using MIDAZOLAM ingredient
Market Authorisation Date: 22 March, 2021
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
MIDAZOLAM IN 0.9% SODIUM CHLORIDE family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic